Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lormeau

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|June 25, 1988
Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharidesM Petitou, J C Lormeau, B Perly, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studiesJ M Herbert, A Bernat, F Dol, et al.
Journal of Cellular Physiology|July 1, 1997
Human umbilical vein endothelial cells express high affinity receptors for factor XaF Bono, J P Herault, C Avril, et al.
The Journal of Cell Biology|May 1, 1986
Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate groupJ J Castellot, J Choay, J C Lormeau, et al.
The American Journal of Pathology|December 1, 1991
Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivoL A Pukac, G M Hirsch, J C Lormeau, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Heparin, heparan sulfate, smooth muscle cells, and atherosclerosisM J Karnovsky, T C Wright, J J Castellot, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
New synthetic heparin mimetics able to inhibit thrombin and factor XaM Petitou, P Duchaussoy, P A Driguez, et al.
The Journal of Biological Chemistry|January 25, 1989
Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and chargeT C Wright, J J Castellot, M Petitou, et al.
Biochimie|August 1, 1990
Antithrombin III: structural and functional aspectsL Mourey, J P Samama, M Delarue, et al.
Thrombosis and Haemostasis|April 2, 1999
Contribution of erythrocytes to thrombin generation in whole bloodV Peyrou, J C Lormeau, J P Hérault, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|June 25, 1988
Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharidesM Petitou, J C Lormeau, B Perly, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studiesJ M Herbert, A Bernat, F Dol, et al.
Journal of Cellular Physiology|July 1, 1997
Human umbilical vein endothelial cells express high affinity receptors for factor XaF Bono, J P Herault, C Avril, et al.
The Journal of Cell Biology|May 1, 1986
Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate groupJ J Castellot, J Choay, J C Lormeau, et al.
The American Journal of Pathology|December 1, 1991
Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivoL A Pukac, G M Hirsch, J C Lormeau, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Heparin, heparan sulfate, smooth muscle cells, and atherosclerosisM J Karnovsky, T C Wright, J J Castellot, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
New synthetic heparin mimetics able to inhibit thrombin and factor XaM Petitou, P Duchaussoy, P A Driguez, et al.
The Journal of Biological Chemistry|January 25, 1989
Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and chargeT C Wright, J J Castellot, M Petitou, et al.
Biochimie|August 1, 1990
Antithrombin III: structural and functional aspectsL Mourey, J P Samama, M Delarue, et al.
Thrombosis and Haemostasis|April 2, 1999
Contribution of erythrocytes to thrombin generation in whole bloodV Peyrou, J C Lormeau, J P Hérault, et al.
Pageof 7